KB
Ketan Bhupendrabhai Parikh
About Ketan Bhupendrabhai Parikh
Data last updated:
Ketan Bhupendrabhai Parikh is a Director at Shamrock Pharmachemi Private Limited (since 2022), Additional Director at Unimark Remedies Limited (since 2023) and Director at Shamrock Pharmachem India Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹256 Cr; the largest is Shamrock Pharmachemi Private Limited at ₹151 Cr (FY 2023). Earlier, Ketan Bhupendrabhai Parikh was an Additional Director at Shamrock International Limited (2022) and Director at Shamrock Industrial Company Limited (2017–2022) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shamrock Pharmachemi Private Limited U51900MH1981PTC024607 | Director | 22 Jun 2022 | 1981 | ₹151 Cr (FY 2023) | Active |
 Unimark Remedies Limited U23200MH1993PLC075373 | Additional Director | 27 May 2023 | 1993 | ₹104 Cr (FY 2019) | Active |
 Shamrock Pharmachem India Private Limited U20116MH2023PTC400510 | Director | 10 Apr 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Shamrock International Limited U51900MH1994PLC077080 | Additional Director | 02 May 2022 | 1994 | ₹7.47 Cr (FY 2025) | Active |
| Shamrock Industrial Company Limited L74909MH1991PLC062298 | Director | 10 Apr 2017 | 1991 | Active | |
| Shiraaj Pharmachemi Private Limited U24100MH2019PTC319758 | Director | 20 Apr 2023 | 2019 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ketan Bhupendrabhai Parikh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kamlesh Rameshchandra Khokhani | 00322223 | Shamrock Pharmachemi Private Limited , Unimark Remedies Limited and 1 more | Director |
| Jitesh Khokhani Rameshchandra | 00611815 | Unimark Remedies Limited | Director |
| Kamlesh Rameshchandra Khokhani | Unimark Remedies Limited | Cfo | |
| Sonalika Sushant Shrivastav | 09209953 | Unimark Remedies Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ketan Bhupendrabhai Parikh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ketan Bhupendrabhai Parikh
Ketan Bhupendrabhai Parikh currently holds 3 directorships: Shamrock Pharmachemi Private Limited (Director, since 22 Jun 2022, revenue ₹151 Cr (FY 2023)); Unimark Remedies Limited (Additional Director, since 27 May 2023, revenue ₹104 Cr (FY 2019)); Shamrock Pharmachem India Private Limited (Director, since 10 Apr 2023).
Ketan Bhupendrabhai Parikh was first appointed on 10 Apr 2017 as Director at Shamrock Industrial Company Limited. The most recent appointment on record is 27 May 2023 at Unimark Remedies Limited.
The 2 current companies of Ketan Bhupendrabhai Parikh that report revenue have a combined latest revenue of ₹256 Cr: Shamrock Pharmachemi Private Limited ₹151 Cr (FY 2023); Unimark Remedies Limited ₹104 Cr (FY 2019).
Ketan Bhupendrabhai Parikh held 3 earlier board appointments: Shamrock International Limited (Additional Director, 02 May 2022 to 21 Jun 2022); Shamrock Industrial Company Limited (Director, 10 Apr 2017 to 09 Apr 2022); Shiraaj Pharmachemi Private Limited (Director, from 20 Apr 2023).
The current boards of Ketan Bhupendrabhai Parikh's companies include Kamlesh Rameshchandra Khokhani (Shamrock Pharmachemi Private Limited), Jitesh Khokhani Rameshchandra (Unimark Remedies Limited), Kamlesh Rameshchandra Khokhani (Unimark Remedies Limited), Sonalika Sushant Shrivastav (Unimark Remedies Limited).